Carly Kenselaar

Stock Analyst at Citigroup

(1.89)

# 1,762

Out of 4,497 analysts

3

Total ratings

100%

Success rate

60.83%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Upgrades: Buy	$7 → $10	$9.80	+2.04%	2	Dec 5, 2023
	KRYS Krystal Biotech	Initiates: Buy	$160	$203.66	-21.44%	1	Oct 12, 2023

Travere Therapeutics

Dec 5, 2023

Upgrades: Buy

Price Target: $7 → $10

Current: $9.80

Upside: +2.04%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $203.66

Upside: -21.44%